Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v2-FR
Language English French
Date Updated 2020-12-14 2020-11-09
Drug Identification Number 02460939 02460939
Brand name SANDOZ ESOMEPRAZOLE SANDOZ ESOMEPRAZOLE
Common or Proper name SANDOZ ESOMEPRAZOLE SANDOZ ESOMEPRAZOLE
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients ESOMEPRAZOLE ESOMEPRAZOLE
Strength(s) 40MG 40MG
Dosage form(s) TABLET (DELAYED-RELEASE) TABLET (DELAYED-RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100GRT BO CA 100GRT BO CA
ATC code A02BC A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-11-06 2020-11-06
Estimated end date 2020-12-25 2020-12-18
Actual end date
Shortage status Actual shortage Actual shortage
Company comments
Health Canada comments